SCHEMBL983099

SCHEMBL983099

Oc1ccc(CC(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.55
SLC6A4 P31645 1/20 0.55
SLC6A3 Q01959 1/20 0.55
ESR1 P03372 9/20 0.52
ESR2 Q92731 9/20 0.52
SLC7A5 Q01650 1/20 0.48
TAAR1 Q96RJ0 3/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
FNTA P49354 1/20 0.47
FNTB P49356 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20425314 0.98 ESR1 (0.55) SLC6A2SLC6A4SLC6A3ESR1ESR2
SCHEMBL163773 0.98 ESR1 (0.55) SLC6A2SLC6A4SLC6A3ESR1ESR2
SCHEMBL69283 0.91 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3ESR1ESR2
SCHEMBL231792 0.91 ESR1 (0.61) SLC6A2ESR1ESR2SLC7A5TAAR1
SCHEMBL10615463 0.88 ESR1 (0.54) SLC6A2SLC6A4SLC6A3ESR1ESR2
SCHEMBL6686176 0.87 ESR1 (0.76) SLC6A2SLC6A4SLC6A3ESR1ESR2
SCHEMBL1838937 0.84 ESR1 (0.50) SLC6A2ESR1ESR2SLC7A5TAAR1
SCHEMBL8410262 0.84 ESR1 (0.61) SLC6A2ESR1ESR2SLC7A5TAAR1
SCHEMBL21085645 0.83 LTA4H (0.62) SLC6A2SLC6A3ESR1ESR2MEN1
SCHEMBL318537 0.83 SLC6A2 (0.74) SLC6A2SLC6A4SLC6A3TAAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118496435-B Functional polymer, preparation method and application thereof, tin powder modification method and tin paste 化学与精细化工广东省实验室 2024-10-01 CN claimed
CN-115885984-A Pyraclostrobin and epoxiconazole microemulsion as well as preparation method and application thereof 上海悦联生物科技有限公司 2023-04-04 CN claimed
US-4322312-A Process for purification of non-ionic emulsifiers BAYER AKTIENGESELLSCHAFT (DE) 1982-03-30 US claimed
CN-112394622-B Low-etching-rate developer composition and preparation method thereof 芯越微电子材料(嘉兴)有限公司 2025-05-09 CN disclosed
CN-115885984-A Pyraclostrobin and epoxiconazole microemulsion as well as preparation method and application thereof 上海悦联生物科技有限公司 2023-04-04 CN disclosed
EP-2275405-B1 PROCESS FOR PRODUCING ISOCYANATE USING DIARYL CARBONATE ASAHI CHEMICAL IND (JP) 2019-04-24 EP disclosed
EP-2275406-B1 PROCESS FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2018-11-28 EP disclosed
EP-2792673-B1 Carbamic acid ester derivatives for the production of isocyanate and aromatic hydroxy compounds ASAHI CHEMICAL IND (JP) 2018-07-25 EP disclosed
CN-105264016-B Reinforcing agent for polycarbonate resin, polycarbonate resin composition, and molded article 三菱化学株式会社 2017-11-21 CN disclosed
US-9637445-B2 Isocyanate production process using composition containing carbamic acid ester and aromatic hydroxy compound, and composition for transfer and storage of carbamic acid ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2017-05-02 US disclosed
EP-2147909-B1 METHOD FOR PRODUCTION OF ISOCYANATE USING COMPOSITION COMPRISING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSPORT OR STORAGE OF CARBAMIC ACID ESTER ASAHI CHEMICAL IND (JP) 2016-12-14 EP disclosed
US-20100113823-A1 ISOCYANATE PRODUCTION PROCESS USING COMPOSITION CONTAINING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSFER AND STORAGE OF CARBAMIC ACID ESTER ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-05-06 US disclosed
EP-2147909-A1 METHOD FOR PRODUCTION OF ISOCYANATE USING COMPOSITION COMPRISING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSPORT OR STORAGE OF CARBAMIC ACID ESTER Asahi Kasei Chemicals Corporation (JP) 2010-01-27 EP disclosed
EP-0993481-A1 METHOD FOR PRODUCING BRANCHED POLYCARBONATES Bayer Aktiengesellschaft (DE) 2000-04-19 EP disclosed
US-5932641-A BLEND WITH THERMOSETTING, THERMOPLASTIC POLYMERS COATEX S.A. (FR) 1999-08-03 US disclosed
WO-1999001495-A1 METHOD FOR PRODUCING BRANCHED POLYCARBONATES BAYER AKTIENGESELLSCHAFT (DE) 1999-01-14 WO disclosed
US-4322312-A Process for purification of non-ionic emulsifiers BAYER AKTIENGESELLSCHAFT (DE) 1982-03-30 US disclosed
US-4299959-A N-SUBSTITUTED IMINOCOUMARINS CIBA-GEIGY CORPORATION (US) 1981-11-10 US disclosed
EP-0012875-A1 Non-ionic emulsifying agents and process for their purification BAYER AG (DE) 1980-07-09 EP disclosed
US-4153618-A N-SUBSTITUTED IMINOCOUMARINS CIBA-GEIGY CORPORATION (US) 1979-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113823-A1 ISOCYANATE PRODUCTION PROCESS USING COMPOSITION CONTAINING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSFER AND STORAGE OF CARBAMIC ACID ESTER PAH, APEH, CPS1 SLC6A2 2231/4885SLC6A4 3421/4885SLC6A3 2641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.